Last reviewed · How we verify
NCT05236920: UP-FRONT
Utility and Procedural Feasibility of REBOA Operationalized for Non-Trauma Application (UP-FRONT)
NA trial testing Resuscitative Endovascular balloon occlusion of the aorta using a REBOA catheter device in Cardiac Arrest, Out-Of-Hospital. Withdrawn.
31 October 2022
Quick facts
| Lead sponsor | University of Alabama at Birmingham |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 1 October 2022 |
| Primary completion | 31 October 2022 |
| Estimated completion | 31 October 2022 |
Drugs / interventions tested
- Resuscitative Endovascular balloon occlusion of the aorta using a REBOA catheter device
Conditions studied
- Cardiac Arrest, Out-Of-Hospital — all drugs for Cardiac Arrest, Out-Of-Hospital →
- Ventricular Fibrillation — all drugs for Ventricular Fibrillation →
- Ventricular Tachycardia — all drugs for Ventricular Tachycardia →
Sponsor
University of Alabama at Birmingham
Who can join
Adults 18 to 70, any sex, with Cardiac Arrest, Out-Of-Hospital or Ventricular Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single center randomized-controlled trial in out-of-hospital cardiac arrest (OHCA) patients. This study will investigate the feasibility and utility of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) procedure using a REBOA catheter device in patients who have experienced an OHCA and have not regained return of spontaneous circulation (ROSC).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05236920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Arrest, Out-Of-Hospital
Currently open trials in the same condition.
- NCT07041086 — Prehospital ECPR in Moravia Silesia Region · recruiting
- NCT07026773 — Validity of ICU Clinician's Appraisal of Proportionality in CPR · recruiting
- NCT06491186 — Pulse Checks Using Femoral Artery B-Mode Ultrasound With Compressibility Assessment · recruiting
- NCT05376267 — Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) · NA · recruiting
- NCT05482945 — CardioPulmonary Resuscitation With Argon (CPAr) Trial · Phase 2 · recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
- NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
- NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05236920 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
- Last refreshed: 20 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05236920.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing